Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
Breast cancer is the most common cancer-affecting women with the most common subtype is HER2 positive breast cancer. Patients with HER2 positive breast cancer are treated with Herceptin, a monoclonal anti-HER2 antibody that is proven to improve survival. Unfortunately, the incidence of primary or ac...
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | 英語 |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | http://eprints.usm.my/57782/ |